156 related articles for article (PubMed ID: 1337307)
1. Conversion of premalignant human cells to tumorigenic cells by methylmethane sulfonate and methylnitronitrosoguanidine.
Milo GE; Shuler CF; Stoner G; Chen JC
Cell Biol Toxicol; 1992; 8(4):193-205. PubMed ID: 1337307
[TBL] [Abstract][Full Text] [Related]
2. Nontumorigenic squamous cell carcinoma line converted to tumorigenicity with methyl methanesulfonate without activation of HRAS or MYC.
Milo GE; Shuler C; Kurian P; French BT; Mannix DG; Noyes I; Hollering J; Sital N; Schuller D; Trewyn RW
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1268-72. PubMed ID: 2406716
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of monofunctional alkylating agents. Methyl methanesulfonate and methyl-N'-nitro-N-nitrosoguanidine have different mechanisms of toxicity for 10T1/2 cells.
Smith GJ; Grisham JW
Mutat Res; 1983 Nov; 111(3):405-17. PubMed ID: 6646150
[TBL] [Abstract][Full Text] [Related]
4. Ineffectiveness of the presence of H-ras/p53 combination of mutations in squamous cell carcinoma cells to induce a conversion of a nontumorigenic to a tumorigenic phenotype.
Lee H; Li D; Prior T; Casto BC; Weghorst CM; Shuler CF; Milo GE
Cell Biol Toxicol; 1997 Oct; 13(6):419-34. PubMed ID: 9352120
[TBL] [Abstract][Full Text] [Related]
5. The sensitivities of SV40-transformed human fibroblasts to monofunctional and DNA-crosslinking alkylating agents.
Miyakoshi J; Scudiero DA; Allalunis-Turner J; Day RS
Mutat Res; 1991 Jan; 254(1):55-64. PubMed ID: 1846027
[TBL] [Abstract][Full Text] [Related]
6. Noncorrelative c-myc and ras oncogene expression in squamous cell carcinoma cells with tumorigenic potential.
Shuler C; Kurian P; French BT; Noyes I; Sital N; Hollering J; Trewyn RW; Schuller D; Milo GE
Teratog Carcinog Mutagen; 1990; 10(1):53-65. PubMed ID: 1693449
[TBL] [Abstract][Full Text] [Related]
7. Transformation of immortal, non-tumorigenic osteoblast-like human osteosarcoma cells to the tumorigenic phenotype by nickel sulfate.
Rani AS; Qu DQ; Sidhu MK; Panagakos F; Shah V; Klein KM; Brown N; Pathak S; Kumar S
Carcinogenesis; 1993 May; 14(5):947-53. PubMed ID: 8504488
[TBL] [Abstract][Full Text] [Related]
8. Metastatic conversion of chemically transformed human cells.
Sun XL; Li D; Fang J; Casto B; Noyes I; Milo GE
Gene Expr; 1999; 8(5-6):327-39. PubMed ID: 10947081
[TBL] [Abstract][Full Text] [Related]
9. Neoplastic transformation of primary tracheal epithelial cell cultures.
Pai SB; Steele VE; Nettesheim P
Carcinogenesis; 1983; 4(4):369-74. PubMed ID: 6839411
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human cells transformed in vitro by N-methyl-N'-nitro-N-nitrosoguanidine.
Rhim JS; Putman DL; Arnstein P; Huebner RJ; McAllister RM
Int J Cancer; 1977 Apr; 19(4):505-10. PubMed ID: 265298
[TBL] [Abstract][Full Text] [Related]
11. Apaf-1 deficient mouse fibroblasts are resistant to MNNG and MMS-induced apoptotic death without attenuation of Bcl-2 decline.
Tomicic MT; Christmann M; Fabian K; Kaina B
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):117-22. PubMed ID: 16019050
[TBL] [Abstract][Full Text] [Related]
12. Comparative stages of expression of human squamous carcinoma cells and carcinogen transformed keratinocytes.
Milo GE; Yohn J; Schuller D; Noyes I; Lehman T
J Invest Dermatol; 1989 Jun; 92(6):848-53. PubMed ID: 2470830
[TBL] [Abstract][Full Text] [Related]
13. Rat hepatocytes with elevated metallothionein expression are resistant to N-methyl-N'-nitro-N-nitrosoguanidine cytotoxicity.
Moffatt P; Plaa GL; Denizeau F
Toxicol Appl Pharmacol; 1996 Jan; 136(1):200-7. PubMed ID: 8560476
[TBL] [Abstract][Full Text] [Related]
14. Emergence of neoplastic transformants spontaneously or after exposure to N-methyl-N'-nitro-N-nitrosoguanidine in populations of rat liver epithelial cells cultured under selective and nonselective conditions.
Lee LW; Tsao MS; Grisham JW; Smith GJ
Am J Pathol; 1989 Jul; 135(1):63-71. PubMed ID: 2774059
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of methylating agents in isolated hepatocytes.
Reitman FA; Shertzer HG; Berger ML
Biochem Pharmacol; 1988 Aug; 37(16):3183-8. PubMed ID: 3401249
[TBL] [Abstract][Full Text] [Related]
16. Clonal analysis of the stepwise appearance of anchorage independence and tumorigenicity in CAK, a permanent line of mouse cells.
Thomassen DG; DeMars R
Cancer Res; 1982 Oct; 42(10):4054-63. PubMed ID: 7105002
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of carcinogenesis in cultured respiratory tract epithelium by 12-0-tetradecanoylphorbol-13-acetate.
Steele VE; Marchok AC; Nettesheim P
Int J Cancer; 1980 Sep; 26(3):343-8. PubMed ID: 7287211
[TBL] [Abstract][Full Text] [Related]
18. Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine.
Frost P; Liteplo RG; Donaghue TP; Kerbel RS
J Exp Med; 1984 May; 159(5):1491-501. PubMed ID: 6201588
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of cytotoxicity by 3-aminobenzamide in DNA repair-deficient human tumor cell lines following exposure to methylating agents or anti-neoplastic drugs.
Babich MA; Day RS
Carcinogenesis; 1988 Apr; 9(4):541-6. PubMed ID: 3356063
[TBL] [Abstract][Full Text] [Related]
20. Cloning and sequencing of CATR1.3, a human gene associated with tumorigenic conversion.
Li D; Noyes I; Shuler C; Milo GE
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6409-13. PubMed ID: 7604004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
